MORE►
McKesson Corp.
Jason Hammonds, COO of oncology and specialty for McKesson (left) and Marcus Neubauer, MD, chief medical officer for The US Oncology Network [Photos: LinkedIn]
McKesson Launches Initiative to Advance Precision Medicine in Community Oncology
by Lance Murray | Apr 22, 2025
Precision Care Companion (PCC) is a consortium of industry experts, led by McKesson, designed to help healthcare practices improve patient care.
by Lance Murray |
Feb 4, 2025
McKesson said it will acquire an 80% interest in the provider of general ophthalmology and retina management services. PRISM Vision physicians will continue to retain a 20% interest in their company.
MORE►
by Lance Murray |
Oct 1, 2024
McKesson said that with a scalable, flexible suite of services and an experienced leadership team, InspiroGene enables manufacturers, payers, and providers to navigate the complex CGT commercialization landscape—ensuring that "patients can access the life-changing treatments they need."
MORE►
by Lance Murray |
Aug 26, 2024
Florida-based Core Ventures was established by the Florida Cancer Specialists & Research Institute, a physician-owned community oncology practice. With the multi-billion-dollar acquisition, CORE Ventures will join McKesson's US Oncology Network to advance "affordable cancer care and better patient outcomes."
MORE►
Meet the Finalists: The Innovation Awards 2022, Presented by Dallas Innovates and D CEO
by Dallas Innovates | Staff Report | Oct 26, 2021
Now in its third year, the program from Dallas Innovates and D CEO honors 78 disruptors and trailblazers driving a new vision for innovation in North Texas.
MORE►
